Literature DB >> 19221917

Citation bias in reported smoking prevalence in people with schizophrenia.

Simon Chapman1, Mark Ragg, Kevin McGeechan.   

Abstract

OBJECTIVE: A meta-analysis of 42 studies on tobacco smoking among schizophrenia subjects found an average smoking prevalence of 62% (range=14-88%). Statements are common, however, in the research literature and the media that between 80% and 90% of people with schizophrenia smoke. The purpose of the present paper was therefore to determine if citation bias exists in the over-citation and reportage of studies finding high rates of smoking prevalence in schizophrenia subjects.
METHODS: Two hypotheses were tested: (i) that studies on the prevalence of smoking in people with schizophrenia reporting high smoking rates would be cited more often than studies reporting lower rates; and (ii) that statements about smoking rates among schizophrenic people on the Internet would report very high rates more often than more realistic, less dramatic rates.
RESULTS: A 10% increase in reported prevalence of smoking was associated with a 61% (95% confidence interval (CI)=30-98%) increase in citation rate. Journal impact factor (IF) was significantly associated with citation rate (p=0.001) but the country in which a study was carried out did not have an effect (p=0.90). After adjusting for IF, a 10% increase in prevalence of smoking was associated with a 28% increase (95%CI=1-62%) in citation rate. This bias is mirrored on the Internet, where statements abound about uncommonly highly rates of smoking by people with schizophrenia.
CONCLUSIONS: Studies reporting very high prevalence of smoking among people with schizophrenia are cited more often than those studies reporting a low prevalence, a result consistent with citation bias. This citation bias probably contributes to the misinformation available on the Internet, and may have adverse policy and clinical implications.

Entities:  

Mesh:

Year:  2009        PMID: 19221917     DOI: 10.1080/00048670802653372

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  28 in total

1.  Online comments on smoking bans in psychiatric hospitals units.

Authors:  Cati G Brown-Johnson; Ashley Sanders-Jackson; Judith J Prochaska
Journal:  J Dual Diagn       Date:  2014

Review 2.  Evaluation of the clinical efficacy of asenapine in schizophrenia.

Authors:  Arpi Minassian; Jared W Young
Journal:  Expert Opin Pharmacother       Date:  2010-08       Impact factor: 3.889

Review 3.  Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.

Authors:  Manoranjan S D'Souza; Athina Markou
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

4.  Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion.

Authors:  Matthew Schrag; Claudius Mueller; Udochukwu Oyoyo; Mark A Smith; Wolff M Kirsch
Journal:  Prog Neurobiol       Date:  2011-05-11       Impact factor: 11.685

5.  Insular and anterior cingulate circuits in smokers with schizophrenia.

Authors:  Lauren V Moran; Hemalatha Sampath; Elliot A Stein; L Elliot Hong
Journal:  Schizophr Res       Date:  2012-09-27       Impact factor: 4.939

6.  Brain circuits that link schizophrenia to high risk of cigarette smoking.

Authors:  Lauren V Moran; Hemalatha Sampath; Peter Kochunov; L Elliot Hong
Journal:  Schizophr Bull       Date:  2012-12-12       Impact factor: 9.306

7.  A CHRNA5 allele related to nicotine addiction and schizophrenia.

Authors:  L E Hong; X Yang; I Wonodi; C A Hodgkinson; D Goldman; O C Stine; E S Stein; G K Thaker
Journal:  Genes Brain Behav       Date:  2011-04-06       Impact factor: 3.449

Review 8.  Genetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findings.

Authors:  Jose de Leon; Francisco J Diaz
Journal:  Hum Genet       Date:  2011-12-22       Impact factor: 4.132

Review 9.  Seizure associated with clozapine: incidence, etiology, and management.

Authors:  Andrew M Williams; Susie H Park
Journal:  CNS Drugs       Date:  2015-02       Impact factor: 5.749

10.  Modifiers of short-term effects of ozone on mortality in eastern Massachusetts--a case-crossover analysis at individual level.

Authors:  Cizao Ren; Steve Melly; Joel Schwartz
Journal:  Environ Health       Date:  2010-01-21       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.